Metis Technologies Secures RMB 400 Million in Series D Financing to Fuel Beijing’s Biopharmaceutical Innovation
Metis Technologies announces the successful closure of its Series D financing round, raising RMB 400…
Biopharmaceutical
Beijing’s Biopharmaceutical Sector Gets Major Boost with Metis Technologies’ Series D Financing
Metis Technologies closes RMB 400 million Series D financing to drive innovation in Beijing's biopharmaceutical…
Biotech Giant Invests in Virginia with Massive New Plant
A leading biopharmaceutical company has announced plans to build a multi-billion dollar plant in Virginia,…
AstraZeneca to Inject $50 Billion into US Economy by 2030
AstraZeneca plans to invest $50 billion in the US economy by 2030, creating new jobs…